These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31698824)

  • 1. Parenterally Administered P24-VP8* Nanoparticle Vaccine Conferred Strong Protection against Rotavirus Diarrhea and Virus Shedding in Gnotobiotic Pigs.
    Ramesh A; Mao J; Lei S; Twitchell E; Shiraz A; Jiang X; Tan M; Yuan AL
    Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31698824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA-Based Vaccines Are Highly Immunogenic and Confer Protection in the Gnotobiotic Pig Model of Human Rotavirus Diarrhea.
    Hensley C; Roier S; Zhou P; Schnur S; Nyblade C; Parreno V; Frazier A; Frazier M; Kiley K; O'Brien S; Liang Y; Mayer BT; Wu R; Mahoney C; McNeal MM; Petsch B; Rauch S; Yuan L
    Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and intestinal antibody responses to NSP4 enterotoxin of Wa human rotavirus in a gnotobiotic pig model of human rotavirus disease.
    Iosef C; Chang KO; Azevedo MS; Saif LJ
    J Med Virol; 2002 Sep; 68(1):119-28. PubMed ID: 12210439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Live Oral Priming and Intramuscular Boosting Regimen with Rotarix
    Hensley C; Nyblade C; Zhou P; Parreño V; Ramesh A; Frazier A; Frazier M; Garrison S; Fantasia-Davis A; Cai R; Huang PW; Xia M; Tan M; Yuan L
    Vaccines (Basel); 2023 May; 11(5):. PubMed ID: 37243031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine in a neonatal gnotobiotic pig disease model.
    Kandasamy S; Chattha KS; Vlasova AN; Rajashekara G; Saif LJ
    Gut Microbes; 2014; 5(5):639-51. PubMed ID: 25483333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermostable, Dissolvable Buccal Film Rotavirus Vaccine Is Highly Effective in Neonatal Gnotobiotic Pig Challenge Model.
    Hensley C; Zhou P; Schnur S; Mahsoub HM; Liang Y; Wang MX; Page C; Yuan L; Bronshtein V
    Vaccines (Basel); 2021 Apr; 9(5):. PubMed ID: 33946555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic Lactobacillus rhamnosus GG enhanced Th1 cellular immunity but did not affect antibody responses in a human gut microbiota transplanted neonatal gnotobiotic pig model.
    Wen K; Tin C; Wang H; Yang X; Li G; Giri-Rachman E; Kocher J; Bui T; Clark-Deener S; Yuan L
    PLoS One; 2014; 9(4):e94504. PubMed ID: 24722168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults.
    Fix AD; Harro C; McNeal M; Dally L; Flores J; Robertson G; Boslego JW; Cryz S
    Vaccine; 2015 Jul; 33(31):3766-72. PubMed ID: 26065919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotic as Adjuvant Significantly Improves Protection of the Lanzhou Trivalent Rotavirus Vaccine against Heterologous Challenge in a Gnotobiotic Pig Model of Human Rotavirus Infection and Disease.
    Parreno V; Bai M; Liu F; Jing J; Olney E; Li G; Wen K; Yang X; Castellucc TB; Kocher JF; Zhou X; Yuan L
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses.
    Xia M; Huang P; Jiang X; Tan M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33419150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of rotavirus NSP4 protein on the immune response and protection of the S
    Liu C; Huang P; Zhao D; Xia M; Zhong W; Jiang X; Tan M
    Vaccine; 2021 Jan; 39(2):263-271. PubMed ID: 33309483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin Vaccination against Rotavirus Using Microneedles: Proof of Concept in Gnotobiotic Piglets.
    Wang Y; Vlasova A; Velasquez DE; Saif LJ; Kandasamy S; Kochba E; Levin Y; Jiang B
    PLoS One; 2016; 11(11):e0166038. PubMed ID: 27824918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tandem truncated rotavirus VP8* subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenic.
    Wen X; Cao D; Jones RW; Hoshino Y; Yuan L
    Hum Vaccin Immunother; 2015; 11(10):2483-9. PubMed ID: 26091081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin A deficiency impairs adaptive B and T cell responses to a prototype monovalent attenuated human rotavirus vaccine and virulent human rotavirus challenge in a gnotobiotic piglet model.
    Chattha KS; Kandasamy S; Vlasova AN; Saif LJ
    PLoS One; 2013; 8(12):e82966. PubMed ID: 24312675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protection.
    Azevedo MS; Yuan L; Iosef C; Chang KO; Kim Y; Nguyen TV; Saif LJ
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):12-20. PubMed ID: 14715539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal vitamin A deficiency impairs adaptive immune responses to pentavalent rotavirus vaccine (RotaTeq®) in a neonatal gnotobiotic pig model.
    Kandasamy S; Chattha KS; Vlasova AN; Saif LJ
    Vaccine; 2014 Feb; 32(7):816-24. PubMed ID: 24380684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.
    González AM; Nguyen TV; Azevedo MS; Jeong K; Agarib F; Iosef C; Chang K; Lovgren-Bengtsson K; Morein B; Saif LJ
    Clin Exp Immunol; 2004 Mar; 135(3):361-72. PubMed ID: 15008967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice.
    Xia M; Huang P; Jiang X; Tan M
    Vaccine; 2019 Jul; 37(30):4103-4110. PubMed ID: 31201052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine.
    Li Y; Xue M; Yu L; Luo G; Yang H; Jia L; Zeng Y; Li T; Ge S; Xia N
    Vaccine; 2018 Apr; 36(16):2086-2092. PubMed ID: 29555220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease.
    Yuan L; Ward LA; Rosen BI; To TL; Saif LJ
    J Virol; 1996 May; 70(5):3075-83. PubMed ID: 8627786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.